HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mei Jing Lim Selected Research

Therapeutic Uses

1/2016Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mei Jing Lim Research Topics

Disease

1Hypoxia (Hypoxemia)
01/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2016
1Neoplasms (Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

1vatalanib (PTK787)IBA
01/2016
1ChromatinIBA
01/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016
1Therapeutic UsesIBA
01/2016

Therapy/Procedure

1Aftercare (After-Treatment)
01/2016
1Therapeutics
01/2016